Previous Close | 42.57 |
Open | 42.90 |
Bid | 43.27 x 900 |
Ask | 43.27 x 900 |
Day's Range | 42.75 - 43.34 |
52 Week Range | 33.33 - 43.84 |
Volume | |
Avg. Volume | 3,445,390 |
Market Cap | 88.298B |
Beta (5Y Monthly) | 0.27 |
PE Ratio (TTM) | 15.86 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 1.47 (3.45%) |
Ex-Dividend Date | May 16, 2024 |
1y Target Est | N/A |
The University of Toronto's Leslie Dan Faculty of Pharmacy has announced the appointments of two leading scientists as endowed GSK research chairs. These appointments represent the collaborative efforts between the two organizations to advance the field of pharmacy and drive positive change in patient care.
GSK is proud to announce new charitable partnerships in STEM (science, technology, engineering and math) education for underrepresented communities and environmental sustainability. The company's newest philanthropic collaborations are an exciting opportunity to support our commitment to the health of our planet and the next generation of scientists in an equal and inclusive manner.
PHILADELPHIA, March 16, 2024--RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancer